Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by wildbird1on Jan 19, 2020 12:07pm
255 Views
Post# 30570889

RE:Tripp at InvestorIntel

RE:Tripp at InvestorIntelWhile we wait, why not listen one more time to J.Tripp video.

Time 0:30
J.Tripp said "Oncore pharma came to us".

"came to us'...I like that.

Time 1:30 J.Tripp said " we are starting to see revenue into year end".

This video doesn't show a company that has financial problems. Like many investors on this board, I believe we will need a PP to develop and promote Aristotle.
But every single day that goes by without a PP indicate that SZLS has some money left in the Bank.


Nolo wrote: I don't remember seeing anyone post this one so I'll do it myself:

https://www.youtube.com/watch?v=DPdlduM9s7I

It's another Tripp interview at InvestorIntel. From what I could read into what he says, I don't expect anything from Q3. But, if he is true to his words, Q4 will be very interesting. Talking about the telehealth results and impact, he says at 2:38: 'Oh boy are we starting to lift off.' So, there must be something going on that we don't see yet and that we may not see for a few months still. 

A little bit further, he is asked about hypothetical questions that investors could ask him. He brings up the large healthcare group, saying that people don't seem to believe they actually have that deal. Which made me smile because it's almost as if he's saying that in response of what he read here on SH in the past few months. Or maybe through all the rants he got in countless emails. Nevertheless, he knows about our worries but probably can't give a single clue about the deal due to the damn confidentiality agreement. Which could end this week or in a very loooooong time. No way of knowing it. 

Encouraging video overall but it kinds of confirm that everything rests on Q4 for this years numbers. 


Bullboard Posts